Skip to main content
. Author manuscript; available in PMC: 2011 Jun 1.
Published in final edited form as: Retina. 2010 Jun;30(6):930–937. doi: 10.1097/IAE.0b013e3181c720b4

Table 1.

Demographic and clinical data

Patient RFSW ID# Age Gender Time with Diagnosis (yrs) Treatments Lens
1 7689 61 M 10 prednisone, azathioprine, acetazolamide, cyclosporine, triamcinolone, flucinolone implant (OS), 2nd glaucoma (OS) IOL (OD)
IOL (OS)
2 4764 57 F 13 flucinolone implant (OD), prednisone, acetazolamide, diclofenac drops, glaucoma tube (OD), 2nd glaucoma (OD) IOL (OD)
IOL (OS)
3 5026 72 F 13 diclofenac drops +1 nuclear (OS)
+2 nuclear (OD)
4 7986 54 M 6 cyclosporine, acyclovir, cellcept +1 nuclear (OD)
IOL (OS)
5 4771 80 M 13 prednisone, acetazolamide, cyclosporine, triamcinolone, flucinolone implant (OS), 2nd glaucoma (OS) clear (OD)
clear (OS)
6 7758 47 M 2 mycophenolate, triamcinolone, flucinolone implant (OD) clear (OD)
clear (OS)
7 3789 59 M 16 prednisone, diamox clear (OD)
clear (OS)